EU Health Ministers To Deliberate Over Commission’s Pharma Strategy
Plans Get Mixed Reception From Industry Bodies
Executive Summary
A package of health proposals intended to build up the EU’s resilience to health threats while strengthening the competitiveness of Europe’s pharmaceutical industry and ensuring access to affordable drugs takes a major step through the legislative process this week.
You may also be interested in...
Major Review Of EU Pharmaceutical Legislation Kicks Off
The European Commission has launched the process for reshaping and addressing the long-standing weakness in the EU’s pharmaceutical legislation. It has listed in a roadmap the issues it wants to address as it considers policy options for reforms.
Major Review Of EU Pharmaceutical Legislation Kicks Off
The European Commission has launched the process for reshaping and addressing the long-standing weakness in the EU’s pharmaceutical legislation. It has listed in a roadmap the issues it wants to address as it considers policy options for reforms.
EU Pushes For Compulsory Licensing Of Drugs & Vaccines In Health Crises
The EU has published an action plan that is intended to upgrade the bloc’s intellectual property framework while ensuring that goods such as medicines and vaccines are made as widely available as possible. The initiative is part of wide-ranging plans to support member states’ recovery from the pandemic crisis and help ensure the EU’s resilience to future health threats.